Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 5Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, T-Cell, Peripheral 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1

Interventions

Cyclophosphamide 11Peripheral Blood Stem Cell Transplantation 7Filgrastim 6Cytarabine 6Radiotherapy 5Melphalan 5Etoposide 5Cisplatin 5Cyclosporine 4fludarabine phosphate 3Vincristine 3Mycophenolic Acid 3Methylprednisolone 3Indium 3Doxorubicin 3Busulfan 3Antilymphocyte Serum 3sargramostim 2epratuzumab 2Rituximab 2Radioimmunodetection 2Prednisone 2Paclitaxel 2Lym-1 monoclonal antibody 2Carmustine 2motesanib diphosphate 1carbendazim 1VAP-cyclo protocol 1Tacrolimus 1Ritonavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Lymphoma, Large-Cell, Immunoblastic × VAP-cyclo protocol × Clear all
NCT00003578 2013-09-20

High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
500 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡